REGN/SNY—FDA grants priority for Zaltrap in mCRC: http://finance.yahoo.com/news/sanofi-regeneron-announce-regulatory-clinical-050000688.html The PDUFA date is 8/12/12. This BLA was withdrawn in Dec 2011 due to CMC issues and was resubmitted in February 2012.